VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial

Previous
Previous

Press Release: Health Wildcatters’ 2024 edition of Texas Healthcare Challenge Integrates AI Features to Accelerate Healthcare Innovation in Annual Hackathon

Next
Next

Startups Developing Lung Cancer Screening